Key result
FLIPR Calcium 6 and Cal-520 AM dyes both displayed robust calcium transients with high signal-to-noise ratios and were suitable for drug-screening using iPSC-derived human cardiomyocytes.
FLIPR Calcium 6 and Cal-520 AM are suitable and robust fluorescent dyes for high-throughput drug screening of calcium transients in human iPSC-derived cardiomyocytes.
May facilitate high-throughput calcium screening in iPSC-cardiomyocyte models; extends in vitro tools but leaves open clinical translation.
Calcium (Ca2+) plays a central role in regulating many biological processes in the cell from muscle contraction to neurotransmitter release. The need for reliable fluorescent calcium indicator dyes is of vast importance for studying many aspects of cell biology as well as screening compounds using phenotypic high throughput assays. We have assessed two of the latest generation of calcium indicator dyes, FLIPR Calcium 6 and Cal-520 AM for studying calcium transients (CaTs) in induced pluripotent stem cell (iPSC) -derived human cardiomyocytes. FLIPR Calcium 6 and Cal-520 dyes both displayed robust CaTs with a high signal-to-noise ratio (SNR) and were non-toxic to the cells. The analysis showed that CaT amplitudes were stable between measurements, but CaT duration was more variable and tended to increase between reads. Two methods were compared for drug-screening hit-selection; difference in average (unstandardized) and standardized difference. The unstandardized difference was better for assessing CaT amplitude, whereas standardized difference was equal to or better for assessing CaT duration. In summary, FLIPR Calcium 6 and Cal-520 are suitable dyes for drug-screening using iPSC-derived human cardiomyocytes.
No takes yet. Share an insight, caveat, or question.
Daily et al. (2017) studied In vitro compound screening. FLIPR Calcium 6 and Cal-520 AM was evaluated on Calcium transient amplitude and duration. FLIPR Calcium 6 and Cal-520 AM dyes both displayed robust calcium transients with high signal-to-noise ratios and were suitable for drug-screening using iPSC-derived human cardiomyocytes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: